Peter M. Wehmeier
About
Peter M. Wehmeier is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience.
According to data from OpenAlex, Peter M. Wehmeier has authored 24 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 13 papers in Clinical Psychology and 9 papers in Cognitive Neuroscience. Recurrent topics in Peter M. Wehmeier's work include Attention Deficit Hyperactivity Disorder (17 papers), Child and Adolescent Psychosocial and Emotional Development (12 papers) and Neural and Behavioral Psychology Studies (6 papers). Peter M. Wehmeier is often cited by papers focused on Attention Deficit Hyperactivity Disorder (17 papers), Child and Adolescent Psychosocial and Emotional Development (12 papers) and Neural and Behavioral Psychology Studies (6 papers). Peter M. Wehmeier collaborates with scholars based in Germany, Spain and Austria. Peter M. Wehmeier's co-authors include Alexander Schacht, Regina Dittmann, Tobias Banaschewski, Rodrigo Escobar, Martin Lehmann, Gerd Lehmkuhl, Thomas Wagner, Christian Wolff, Aribert Rothenberger and Manfred Döpfner and has published in prestigious journals such as Schizophrenia Research, Journal of Clinical Psychopharmacology and European Psychiatry.
In The Last Decade
Peter M. Wehmeier
24 papers receiving 306 citations
Peers
Peter M. Wehmeier
Raquel Vidal Spain
Valentin Mbékou Canada
Michal Goetz Czechia
Renata R. Kieling Brazil
Ewa Ahnemark Sweden
Kathleen Herzig United States
Helene Barone Halleland Norway
Alessio Bellato United Kingdom
Hilary Galloway-Long United States
Dayna Yorks United States
Citations per year, relative to Peter M. Wehmeier Peter M. Wehmeier (= 1×)
peers
Raquel Vidal
Countries citing papers authored by Peter M. Wehmeier
Since
Specialization
Citations
This map shows the geographic impact of Peter M. Wehmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Wehmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Wehmeier more than expected).
Fields of papers citing papers by Peter M. Wehmeier
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Peter M. Wehmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Wehmeier. The network helps show where Peter M. Wehmeier may publish in the future.
Co-authorship network of co-authors of Peter M. Wehmeier
This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Wehmeier. A scholar is included among the top collaborators of Peter M. Wehmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Wehmeier. Peter M. Wehmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Wehmeier, Peter M., et al.. (2020). Development and Validation of a BriefMeasure of Self-Management Competence:The Self-Management Self-Test (SMST). Therapeutic Innovation & Regulatory Science. 54(3). 534–543.
2.
Gebhardt, G., et al.. (2018). The effects of music therapy on the interaction of the self and emotions—An interim analysis. Complementary Therapies in Medicine. 41. 61–66.
3.
Wehmeier, Peter M., Regina Dittmann, & Tobias Banaschewski. (2014). Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study. ADHD Attention Deficit and Hyperactivity Disorders. 7(2). 165–174.
4.
Dittmann, Regina, Tobias Banaschewski, Alexander Schacht, & Peter M. Wehmeier. (2014). Findings from the observational COMPLY study in children and adolescents with ADHD: core symptoms, ADHD-related difficulties, and patients’ emotional expression during psychostimulant or nonstimulant ADHD treatment. ADHD Attention Deficit and Hyperactivity Disorders. 6(4). 291–302.
5.
Wehmeier, Peter M., Alexander Schacht, Martin Lehmann, et al.. (2012). Does Atomoxetine Improve Executive Function, Inhibitory Control, and Hyperactivity?. Journal of Clinical Psychopharmacology. 32(5). 653–660.
6.
Sobanski, Esther, et al.. (2012). Driving performance in adults with ADHD: Results from a randomized, waiting list controlled trial with atomoxetine. European Psychiatry. 28(6). 379–385.
7.
Wehmeier, Peter M., Alexander Schacht, Rodrigo Escobar, Amaia Hervás, & R. A. Dickson. (2012). Health-related quality of life in ADHD: a pooled analysis of gender differences in five atomoxetine trials. ADHD Attention Deficit and Hyperactivity Disorders. 4(1). 25–35.
8.
Wehmeier, Peter M., Regina Dittmann, Tobias Banaschewski, & Alexander Schacht. (2012). Does Stimulant Pretreatment Modify Atomoxetine Effects on Core Symptoms of ADHD in Children Assessed by Quantitative Measurement Technology?. Journal of Attention Disorders. 18(2). 105–116.
9.
Wehmeier, Peter M., et al.. (2012). Does Comorbid Disruptive Behavior Modify the Effects of Atomoxetine on ADHD Symptoms as Measured by a Continuous Performance Test and a Motion Tracking Device?. Journal of Attention Disorders. 19(7). 591–602.
10.
Wehmeier, Peter M., et al.. (2011). Neuropsychological Outcomes Across the Day in Children with Attention-Deficit/Hyperactivity Disorder Treated with Atomoxetine: Results from a Placebo-Controlled Study Using a Computer-Based Continuous Performance Test Combined with an Infra-Red Motion-tracking Device. Journal of Child and Adolescent Psychopharmacology. 21(5). 433–444.
11.
Schacht, Alexander, Rodrigo Escobar, Thomas Wagner, & Peter M. Wehmeier. (2011). Psychometric properties of the quality of life scale Child Health and Illness Profile-Child Edition in a combined analysis of five atomoxetine trials. ADHD Attention Deficit and Hyperactivity Disorders. 3(4). 335–349.
12.
Escobar, Rodrigo, Alexander Schacht, Peter M. Wehmeier, & Thomas Wagner. (2010). Quality of Life and Attention-Deficit/Hyperactivity Disorder Core Symptoms. Journal of Clinical Psychopharmacology. 30(2). 145–151.
13.
Wehmeier, Peter M., et al.. (2010). Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials. Child and Adolescent Psychiatry and Mental Health. 4(1). 30–30.
14.
Wehmeier, Peter M., Alexander Schacht, Regina Dittmann, & Tobias Banaschewski. (2010). Reasons for Physicians Choice of Medication in Medication-Naive Patients with ADHD: Baseline Data from the COMPLY Observational Study. Current Drug Therapy. 5(2). 139–150.
15.
Wehmeier, Peter M., Alexander Schacht, & Aribert Rothenberger. (2009). Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years. Child and Adolescent Psychiatry and Mental Health. 3(1). 3–3.
16.
Dittmann, Regina, Peter M. Wehmeier, Alexander Schacht, Martin Lehmann, & Gerd Lehmkuhl. (2009). Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings. ADHD Attention Deficit and Hyperactivity Disorders. 1(2). 187–200.
17.
Dittmann, Regina, Peter M. Wehmeier, Alexander Schacht, et al.. (2009). Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians. Child and Adolescent Psychiatry and Mental Health. 3(1). 21–21.
18.
Wehmeier, Peter M., Alexander Schacht, Regina Dittmann, & Manfred Döpfner. (2008). Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: Reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day. Child and Adolescent Psychiatry and Mental Health. 2(1). 10–10.
19.
Lambert, Martin, Benno G. Schimmelmann, Alexander Schacht, et al.. (2008). 395 – Long-term patterns of subjective well-being in schizophrenia: clusters, predictors of cluster affiliation and their relation to recovery in 2842 patients followed over 3 years. Schizophrenia Research. 98. 196–197.
20.
Wehmeier, Peter M.. (2002). Buchbesprechung. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie. 30(2). 149–150.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Raquel Vidal Breakdown of academic impact, for papers by Valentin Mbékou Breakdown of academic impact, for papers by Michal Goetz Breakdown of academic impact, for papers by Renata R. Kieling Breakdown of academic impact, for papers by Ewa Ahnemark Breakdown of academic impact, for papers by Kathleen Herzig Breakdown of academic impact, for papers by Helene Barone Halleland Breakdown of academic impact, for papers by Alessio Bellato Breakdown of academic impact, for papers by Hilary Galloway-Long Breakdown of academic impact, for papers by Dayna Yorks